Preface—molecular genetics of lung cancer

Por Cooper, Wendy A.
Publicado no Transl Lung Cancer Res (2015)

Molecular biology of lung cancer

Por Cooper, Wendy A., Lam, David C. L., O’Toole, Sandra A., Minna, John D.
Publicado em 2013

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Por Wang, Shu, Yu, Bing, Ng, Chiu Chin, Mercorella, Belinda, Selinger, Christina I., O’Toole, Sandra A., Cooper, Wendy A.
Publicado no Transl Lung Cancer Res (2015)

BRAF mutations in non-small cell lung cancer

Por Luk, Peter P., Yu, Bing, Ng, Chiu Chin, Mercorella, Belinda, Selinger, Christina, Lum, Trina, Kao, Steven, O’Toole, Sandra A., Cooper, Wendy A.
Publicado no Transl Lung Cancer Res (2015)

Screening for ROS1 gene rearrangements in non-small cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target

Por Selinger, Christina I, Li, Bob T, Pavlakis, Nick, Links, Matthew, Gill, Anthony J, Lee, Adrian, Clarke, Stephen, Tran, Thang N, Lum, Trina, Yip, Po Yee, Horvath, Lisa, Yu, Bing, Kohonen-Corish, Maija RJ, O’Toole, Sandra A, Cooper, Wendy A
Publicado no Histopathology (2016)

A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma

Por Kao, Steven C, Kirschner, Michaela B, Cooper, Wendy A, Tran, Thang, Burgers, Sjaak, Wright, Casey, Korse, Tiny, van den Broek, Daan, Edelman, James, Vallely, Michael, McCaughan, Brian, Pavlakis, Nick, Clarke, Stephen, Molloy, Mark P, van Zandwijk, Nico, Reid, Glen
Publicado no Br J Cancer (2016)